The first SARS-CoV-2 wave among pregnant women in Italy: results from a prospective population-based study

Ann Ist Super Sanita. 2021 Oct-Dec;57(4):272-285. doi: 10.4415/ANN_21_04_02.

Abstract

Introduction: This study aimed to estimate the incidence of SARS-CoV-2 infection among pregnant women during the first pandemic wave in Italy, and to describe COVID-19 disease characteristics and maternal and perinatal outcomes.

Materials and methods: National population-based prospective cohort study collecting information on women with SARS-CoV-2 diagnosis, confirmed within 7 days from hospital admission.

Results: The national SARS-CoV-2 rate was 6.04 per 1,000 births (95% CI 5.62-6.49) among pregnant women and 7.54 (95% CI 7.47-7.61) among women in reproductive age. 72.1% of the cohort developed mild COVID-19 disease without pneumonia nor need for ventilatory support. Severe disease was significantly associated with women's previous comorbidities (OR 2.55; 95% CI 0.98-6.90), obesity (OR 4.76; 95% CI 1.79-12.66) and citizenship from High Migration Pressure Countries (OR 3.43; 95% CI 1.27-9.25).

Conclusions: During the first pandemic wave in Italy, the SARS-CoV-2 rate among pregnant women was lower compared to that detected among women of reproductive age, and risks of severe COVID-19 disease and adverse maternal and perinatal outcomes were rare.

MeSH terms

  • COVID-19 Testing
  • COVID-19*
  • Citizenship
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications, Infectious* / epidemiology
  • Pregnant Women
  • Prospective Studies
  • SARS-CoV-2